PEPFAR, Partners Announce $85M To Support DREAMS Innovation Challenge Winners In Sub-Saharan Africa
PEPFAR: PEPFAR and DREAMS Partners Announce Winners of the $85 Million DREAMS Innovation Challenge
“[Monday], the U.S. President’s Emergency Plan for AIDS Relief (PEPFAR); Janssen Pharmaceutica NV (Janssen), one of the Janssen pharmaceutical companies of Johnson & Johnson; and ViiV Healthcare announced a combined $85 million investment to support 56 DREAMS Innovation Challenge [provisional] winners in 10 sub-Saharan African countries. Of this investment, $40 million is focused on keeping girls in secondary school, which dramatically reduces their vulnerability to HIV infection, and nearly half of these education-focused resources are directed to Malawi…” (7/18).
The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.